Issue 3, 2022

The latest edition of Modern Medicine is now available for you to read. We have some great articles featured in this edition:

  • Ethics (CPD) – Go Gentle into that Good Night : The Challenges of Discussing Death and Dying
  • Pulmonology (CPD) – Advanced Respiratory Diseases
  • Endocrinology – Assessing for Diabetes-related Complications
  • Oncology (CPD) – Keratinocyte Skin Cancers- Diagnosis and current management
  • … and many more !

Also, a reminder that, not only do we have CPD questions available within the magazine itself, we also have an online CPD portal that allows you to score even more points by simply completing your test online

Keratinocyte Skin Cancers: Diagnosis and current management

Keratinocyte Skin Cancers: Diagnosis and current management

Keratinocyte cancers, formerly known as nonmelanoma skin cancers, are an important cause of morbidity and mortality in South Africa, which is second only after Australia for their prevalence. In 2019, Cancer Council Australia published updated guidelines on diagnosis and management of keratinocyte cancers. This summary for GPs incorporates the latest update.

Modern Medicine – Issue 3 2022

Break the Vicious Circle of Ringworm Transmission

Break the Vicious Circle of Ringworm Transmission

The diagnosis of tinea corporis is usually clinical and should pose no problem to the doctor provided the lesion is typical. However, many clinical variants of tinea corporis exist, rendering the diagnosis difficult especially with prior use of medications, such as calcineurin inhibitors or corticosteroids. As such, doctors must be familiar with this condition so that an accurate diagnosis can be made and appropriate treatment initiated.

Modern Medicine – Issue 3 2022

European Guidelines on Lipid Modification for Cardiovascular Modification

European Guidelines on Lipid Modification for Cardiovascular Modification

The emergence of a substantial body of evidence over the last few years has required new, up-to-date European Society of Cardiology and European Atherosclerosis Society ( E S C – E A S ) guidelines . Fenofibrate, a peroxisome proliferatoractivated receptor-α agonist, has been suggested as an important treatment opt ion in the management of dyslipidaemia owing to its effects on hypertriglyceridaemia and low high-density lipoproteincholesterol ( H D L – C ) concentrations.

Modern Medicine – Issue 3 2022

Assessing for Diabetes-related Complications

Assessing for Diabetes-related Complications

The duration of type 2 diabetes is increasing owing to the global trend towards obesity and younger age of onset. Screening for microvascular and macrovascular complications is recommended for people with either type 1 or type 2 diabetes. People with type 1 diabetes should be screened for associated autoimmune conditions. Treatment targets, especially glycated haemoglobin level (HbA1c), should be individualised, taking into account relative risk and potential adverse effects.

Modern Medicine – Issue 3 2022

Ignoring Adolescent Obesity is a Risk for Later Adult Health

Ignoring Adolescent Obesity is a Risk for Later Adult Health

Adolescent obesity is concerning given its high prevalence and associations with adverse physical, social, and emotional health consequences in adolescence and later in life. It also poses a considerable financial burden on the healthcare system as ~ 70% of adolescents with obesity become adults with obesity. In a randomised, controlled trial of adolescents with obesity, the use of liraglutide (3mg) plus lifestyle therapy led to a significantly greater reduction in the BMI standard-deviation score than placebo plus lifestyle therapy.

Modern Medicine – Issue 3 2022

Advanced Respiratory Disease: Managing symptoms in the last years of life

Advanced Respiratory Disease: Managing symptoms in the last years of life

Symptoms in advanced respiratory disease are varied and commonly include breathlessness, fatigue and cough. Symptom control can be complex and difficult to navigate, particularly in the last few years of life as the disease progresses and patients’ needs escalate. Management is best optimised through holistic approaches, with management of individual symptoms alongside treatment of the underlying disease process.

Modern Medicine – Issue 3 2022

Go Gentle into that Good Night: The Challenges of Discussing Death and Dying

Go Gentle into that Good Night: The Challenges of Discussing Death and Dying

Discussing death and dying is a crucial component of managing life-threatening diseases. Communication at the end-of-life is essential for good patient outcomes in terms of the quality of their care and bereavement outcomes for family and carers. Advanced care planning (ACP) is an important practical component of communication that supports patient autonomy and guides appropriate medical care at the end-of-life.

Modern Medicine – Issue 3 2022